The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10x Genomics Inc | CL A COM | 88025U109 | 381 | 5,000 | SH | SOLE | 1,2 | 5,000 | 0 | 0 | |
Achillion Pharmaceuticals In | COM | 00448Q201 | 44,076 | 7,309,383 | SH | SOLE | 1,2 | 7,309,383 | 0 | 0 | |
Adverum Biotechnologies Inc | COM | 00773U108 | 73,574 | 6,386,607 | SH | SOLE | 1,2,3 | 6,386,607 | 0 | 0 | |
Agenus Inc | COM NEW | 00847G705 | 36,127 | 8,876,391 | SH | SOLE | 1,2,3 | 8,876,391 | 0 | 0 | |
Agilent Technologies Inc | COM | 00846U101 | 12,770 | 149,690 | SH | SOLE | 1,2,3 | 149,690 | 0 | 0 | |
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 188,633 | 1,637,864 | SH | SOLE | 1,2,3 | 1,637,864 | 0 | 0 | |
Apyx Med Corp | COM | 03837C106 | 28,690 | 3,391,279 | SH | SOLE | 1,2,3 | 3,391,279 | 0 | 0 | |
Arbutus Biopharma Corp | COM | 03879J100 | 15,754 | 5,666,754 | SH | SOLE | 1,2,3 | 5,666,754 | 0 | 0 | |
argenx SE | SPONSORED ADR | 04016X101 | 5,097 | 31,752 | SH | SOLE | 1,2 | 31,752 | 0 | 0 | |
Arvinas Inc | COM | 04335A105 | 27,542 | 670,295 | SH | SOLE | 1,2,3 | 670,295 | 0 | 0 | |
Avadel Pharmaceuticals plc | SPONSORED ADR | 05337M104 | 25,681 | 3,401,434 | SH | SOLE | 1,2,3 | 3,401,434 | 0 | 0 | |
Axonics Modulation Tech Inc | COM | 05465P101 | 44,104 | 1,591,632 | SH | SOLE | 1,2,3 | 1,591,632 | 0 | 0 | |
Axsome Therapeutics Inc | COM | 05464T104 | 106,131 | 1,026,813 | SH | SOLE | 1,2,3 | 1,026,813 | 0 | 0 | |
Bellus Health Inc New | COM NEW | 07987C204 | 36,566 | 4,840,992 | SH | SOLE | 1,2,3 | 4,840,992 | 0 | 0 | |
BIOMX Inc | *W EXP 10/16/202 | 09090D111 | 288 | 600,000 | SH | SOLE | 1,2 | 600,000 | 0 | 0 | |
Biomx Inc | COM | 09090D103 | 5,811 | 600,000 | SH | SOLE | 1,2 | 600,000 | 0 | 0 | |
Brainsway Ltd | SPONSORED ADS | 10501L106 | 9,345 | 958,426 | SH | SOLE | 1,2,3 | 958,426 | 0 | 0 | |
Bristol Myers Squibb Co | COM | 110122108 | 105,461 | 1,642,951 | SH | SOLE | 1,2,3 | 1,642,951 | 0 | 0 | |
Castle Biosciences Inc | COM | 14843C105 | 21,690 | 631,072 | SH | SOLE | 1,2,3 | 631,072 | 0 | 0 | |
Clearside Biomedical Inc | COM | 185063104 | 10,875 | 3,750,107 | SH | SOLE | 1,2,3 | 3,750,107 | 0 | 0 | |
Cytomx Therapeutics Inc | COM | 23284F105 | 8,639 | 1,039,593 | SH | SOLE | 1,2,3 | 1,039,593 | 0 | 0 | |
DermTech Inc | COM | 24984K105 | 28,413 | 2,386,871 | SH | SOLE | 1,2 | 2,386,871 | 0 | 0 | |
Dicerna Pharmaceuticals Inc | COM | 253031108 | 129,409 | 5,874,229 | SH | SOLE | 1,2,3 | 5,874,229 | 0 | 0 | |
Establishment Labs Hldgs Inc | COM | G31249108 | 56,217 | 2,032,446 | SH | SOLE | 1,2 | 2,032,446 | 0 | 0 | |
Exagen Inc | COM | 30068X103 | 18,261 | 718,946 | SH | SOLE | 1,2,3 | 718,946 | 0 | 0 | |
Frequency Therapeutics Inc | COM | 35803L108 | 21,762 | 1,302,862 | SH | SOLE | 1,2,3 | 1,302,862 | 0 | 0 | |
Fulgent Genetics Inc | COM | 359664109 | 968 | 75,000 | SH | SOLE | 1,2,3 | 75,000 | 0 | 0 | |
Homology Medicines Inc | COM | 438083107 | 90,029 | 4,349,250 | SH | SOLE | 1,2,3 | 4,349,250 | 0 | 0 | |
Immunovant Inc | COM | 45258J102 | 66,048 | 4,426,106 | SH | SOLE | 1,2,3 | 4,426,106 | 0 | 0 | |
Inmode Ltd | SHS | M5425M103 | 9,800 | 250,000 | SH | SOLE | 1,2 | 250,000 | 0 | 0 | |
Insulet Corp | COM | 45784P101 | 11,595 | 67,725 | SH | SOLE | 1,2,3 | 67,725 | 0 | 0 | |
Johnson & Johnson | COM | 478160104 | 17,046 | 116,858 | SH | SOLE | 1,2 | 116,858 | 0 | 0 | |
La Jolla Pharmaceutical Co | COM PAR $.0001 2 | 503459604 | 8,992 | 2,287,991 | SH | SOLE | 1,2,3 | 2,287,991 | 0 | 0 | |
Masimo Corp | COM | 574795100 | 60,408 | 382,187 | SH | SOLE | 1,2,3 | 382,187 | 0 | 0 | |
Milestone Pharmaceuticals In | COM | 59935V107 | 63,372 | 3,958,264 | SH | SOLE | 1,2,3 | 3,958,264 | 0 | 0 | |
Mirati Therapeutics Inc | COM | 60468T105 | 83,170 | 645,427 | SH | SOLE | 1,2,3 | 645,427 | 0 | 0 | |
Motus Gi Hldgs Inc | COM | 62014P108 | 1,776 | 775,640 | SH | SOLE | 1,2 | 775,640 | 0 | 0 | |
Myokardia Inc | COM | 62857M105 | 55,465 | 760,988 | SH | SOLE | 1,2,3 | 760,988 | 0 | 0 | |
NanoString Technologies Inc | COM | 63009R109 | 16,106 | 578,932 | SH | SOLE | 1,2,3 | 578,932 | 0 | 0 | |
Natera Inc | COM | 632307104 | 13,575 | 402,953 | SH | SOLE | 1,2,3 | 402,953 | 0 | 0 | |
Odonate Therapeutics Inc | COM | 676079106 | 11,577 | 356,752 | SH | SOLE | 1,2,3 | 356,752 | 0 | 0 | |
Personalis Inc | COM | 71535D106 | 2,780 | 255,000 | SH | SOLE | 1,2 | 255,000 | 0 | 0 | |
ProQR Thrapeutics N V | SHS EURO | N71542109 | 47,361 | 4,779,135 | SH | SOLE | 1,2,3 | 4,779,135 | 0 | 0 | |
Protagonist Therapeutics Inc | COM | 74366E102 | 17,343 | 2,459,988 | SH | SOLE | 1,2,3 | 2,459,988 | 0 | 0 | |
PTC Therapeutics Inc | COM | 69366J200 | 184,074 | 3,832,480 | SH | SOLE | 1,2,3 | 3,832,480 | 0 | 0 | |
Regenxbio Inc | COM | 75901B107 | 12,521 | 305,611 | SH | SOLE | 1,2,3 | 305,611 | 0 | 0 | |
Relmada Therapeutics Inc | COM | 75955J402 | 25,915 | 664,484 | SH | SOLE | 1,2,3 | 664,484 | 0 | 0 | |
Rocket Pharmaceuticals Inc | COM | 77313F106 | 382,652 | 16,812,491 | SH | SOLE | 1,2,3,4 | 16,812,491 | 0 | 0 | |
Sarepta Therapeutics Inc | COM | 803607100 | 78,168 | 605,762 | SH | SOLE | 1,2,3 | 605,762 | 0 | 0 | |
STAAR Surgical Co | COM PAR $0.01 | 852312305 | 10,629 | 302,211 | SH | SOLE | 1,2,3 | 302,211 | 0 | 0 | |
Stoke Therapeutics Inc | COM | 86150R107 | 100,373 | 3,544,248 | SH | SOLE | 1,2,3 | 3,544,248 | 0 | 0 | |
Tela Bio Inc | COM | 872381108 | 14,755 | 1,139,358 | SH | SOLE | 1,2,3 | 1,139,358 | 0 | 0 | |
Translate Bio Inc | COM | 89374L104 | 26,901 | 3,304,808 | SH | SOLE | 1,2,3 | 3,304,808 | 0 | 0 | |
Transmedics Group Inc | COM | 89377M109 | 9,567 | 503,266 | SH | SOLE | 1,2 | 503,266 | 0 | 0 | |
Uniqure NV | SHS | N90064101 | 10,899 | 152,096 | SH | SOLE | 1,2,3 | 152,096 | 0 | 0 | |
Vericel Corp | COM | 92346J108 | 52,016 | 2,989,429 | SH | SOLE | 1,2,3 | 2,989,429 | 0 | 0 | |
Viewray Inc | COM | 92672L107 | 633 | 150,000 | SH | SOLE | 1,2,3 | 150,000 | 0 | 0 | |
Vivus Inc 4.5 05/01/2020 | NOTE 4.500% 5/0 | 928551AA8 | 2,918 | 4,000,000 | SH | SOLE | 1 | 4,000,000 | 0 | 0 | |
WAVE Life Sciences Ltd | SHS | Y95308105 | 13,669 | 1,705,474 | SH | SOLE | 1,2,3 | 1,705,474 | 0 | 0 | |
Zimmer Biomet Holdings Inc | COM | 98956P102 | 65,468 | 437,385 | SH | SOLE | 1,2,3 | 437,385 | 0 | 0 |